資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/29756
|
| 標題: | 6-Shogaol Induces cell cycle arrest and apoptosis in human hepatoma cells through pleiotropic mechanisms |
| 作者: | Wu, Jung-Ju
Omar, Hany A.
Lee, Ying-Ray
Teng, Yen-Ni
Chen, Pin-Shern
Chen, Yu-Chung
Huang, Hsiao-Shan
Lee, Kuan-Han
Hung, Jui-Hsiang |
| 貢獻者: | 生物科技系
藥學系暨藥物科技研究所 |
| 關鍵字: | 6-Shogaol
Apoptosis
Cell cycle arrest
Reactive oxygen species
Autophagy
Endoplasmic reticulum stress
Mitogen-actwated protein |
| 日期: | 2015-09 |
| 上傳時間: | 2016-04-19 19:07:04 (UTC+8) |
| 出版者: | Elsevier Science Bv |
| 摘要: | Shogaols are a group of the active constituents of ginger that have been identified to have various biological activities. The aim of the current study was to investigate the antitumor activity of 6-shogaol in hepatocellular carcinoma (HCC) and the possible involvement of reactive oxygen species as a putative mechanism of action. HCC cell lines, HepG2 and Huh-7, were used to study the in vitro anti-cancer activity of 6-shogaol via the application of various molecular biology techniques. Results showed that 6-shogaol effectively inhibited the cell viability, caused cell cycle arrest at G2/M phase and induced apoptosis in HCC cells as indicated by MIT assay, DAPI nuclear staining, annexin V assay, cell cycle analysis, and activation of caspase-3. Western blot analysis revealed the ability of 6-shogaol to target cancer survival signaling pathways mediated by mitogen-activated protein kinase (MAPK), 5 AMP-activated protein kinase (AMPK) and Akt. In addition, 6-Shogaol induced alteration of cyclin proteins expression and caused cleavage of protein kinase C delta. Furthermore, 6-Shogaol was able to induce the production of reactive oxygen species and encloplasmic reticulum (ER) stress-associated proteins and the consequent activation of autophagy in HepG2 cells. Taken together, the current study highlights evidences that 6-shogaol induces apoptosis, modulates cyclins expression and targets cancer survival signaling pathways in HCC cell lines, at least in part, via the production of reactive oxygen species. These findings support 6-shogaol's clinical promise as a potential candidate for HCC therapy. (C)) 2015 Elsevier B.V. All rights reserved |
| 關聯: | European Journal of Pharmacology, v.762, pp.449-458 |
| 顯示於類別: | [藥學系(所)] 期刊論文
[生物科技系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 1680 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
